Researchers investigate effect of epilepsy surgery on patients lives

Resective surgery is an effective treatment for dug-resistant epilepsy. To investigate the effect of epilepsy surgery on patients lives, researchers from the Comprehensive Epilepsy Program at the Henry Ford Hospital in Detroit conducted a long-term retrospective follow up of surgical patients and correlated post-surgical psychosocial outcomes with seizure outcome and brain area surgically treated.

In a research report presented today at the American Epilepsy Society 67th Annual Meeting, the investigators conducted telephone interviews with more than half of all epilepsy surgery patients operated on at their center between 1993 and 2011. Of those contacted, 215 had undergone temporal lobe surgery and 38 had surgery in other brain areas. (Poster 3.249 / Abstract 1749424 -Long-term Post-operative Psychosocial Outcomes after Resective Surgery for Epilepsy.)

More than three-fourths of temporal lobe patients (78%) had a favorable surgical outcome (seizure free or having only rare disabling seizures), and over half of extra-temporal surgical patients (58%) had a similar outcome. Almost all of the patients (92%) considered the surgical treatment to have been worthwhile.

"Our study shows that resective epilepsy surgery not only yields favorable seizure outcomes but psychosocial outcomes, as well," says Vibhangini S. Wasade, M.D., lead author of the study. "Following surgery, more patients were able to drive, and those with favorable seizure outcomes were more likely to be employed full-time and less likely to be taking antidepressants. Overall, the great majority expressed satisfaction in having epilepsy surgery."

Half of the surgical patients (51%) were able to drive at the time of the survey, compared to 35% who were able to do so preoperatively. Patients with a favorable surgical outcome were more likely than those with less favorable outcomes to be currently driving (65% vs. 11%), more likely to be currently working (28% vs. 8%), and less likely to be taking antidepressant medication (24% vs. 47%).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic